首页> 外文期刊>BMC Infectious Diseases >Mortality trends in U.S. adults with septic shock, 2005-2011: a serial cross-sectional analysis of nationally-representative data
【24h】

Mortality trends in U.S. adults with septic shock, 2005-2011: a serial cross-sectional analysis of nationally-representative data

机译:2005-2011年美国败血症性休克成年人死亡率趋势:国家代表性数据的系列横断面分析

获取原文
           

摘要

Background We aimed to investigate mortality trends in hospitalized patients with septic shock in the US. To achieve this objective, we tested hypothesis that mortality decreased in patients identified by the code of septic shock while mortality did not change in those with septic shock identified by vasopressor use. Methods We conducted a serial cross-sectional analysis using Nationwide Inpatient Sample database from 2005 through 2011. First, we identified all adult patients aged ≥18?years hospitalized for septic shock by the following criteria: 1) primary ICD-9 diagnosis of infection plus procedure code for vasopressor use, 2) primary ICD-9 diagnosis of infection plus septic shock in non-primary field, and 3) primary ICD-9 diagnosis of septic shock. Second, we stratified all identified patients by record of vasopressor use. The outcome of interest was year-to-year changes in the in-hospital all-cause mortality. Results From 2005 to 2011, we identified 109,812 weighted hospitalizations with septic shock. Overall, there was a significant downward trend in in-hospital mortality (from 46?% in 2005 to 42?% in 2011; P trend ?=?0.003); the adjusted mortality also decreased significantly (OR for comparison of 2005 with 2011, 0.98; 95 % CI, 0.96–1.00; P trend =0.57); similarly, the adjusted mortality did not change significantly (OR, 1.01; 95 % CI, 0.97–1.05; P =0.62). By contrast, there was a downward trend in mortality in the subgroup without vasopressor use (from 47?% in 2005 to 43?% in 2011; P trend =0.002); likewise, the adjusted mortality decreased significantly (OR, 0.97; 95 % CI, 0.95–0.99; P =0.002) Conclusions From 2005 to 2011, we found a modest decrease in in-hospital mortality among patients identified with septic shock. However, in the subgroup with vasopressor use, we found no significant change in mortality. Our data challenge the conventional wisdom that mortality in this population has improved during the last decade.
机译:背景我们旨在调查美国败血症性休克住院患者的死亡率趋势。为了实现这一目标,我们检验了以下假设:通过败血性休克守则确定的患者死亡率降低,而通过使用血管加压药确定的败血症性休克患者死亡率没有变化。方法我们使用2005年至2011年的全国住院患者样本数据库进行了系列横断面分析。首先,我们通过以下标准确定了所有住院的≥18岁败血症性休克成人患者,其标准如下:1)ICD-9原发性感染加血管加压药使用的程序代码,2)非原发性感染的原发性ICD-9诊断合并感染性休克,3)原发性感染的ICD-9诊断性感染。其次,我们通过血管加压药的使用记录对所有确定的患者进行分层。令人感兴趣的结果是医院内全因死亡率的逐年变化。结果2005年至2011年,我们确定了109,812例因脓毒性休克而加权住院治疗。总体而言,医院内死亡率有显着下降趋势(从2005年的46%下降到2011年的42%; P 趋势?=?0.003);调整后的死亡率也显着降低(2005年与2011年相比,OR为0.98; 95%CI为0.96–1.00; P趋势 = 0.57);同样,调整后的死亡率也没有显着变化(OR,1.01; 95%CI,0.97-1.05; P = 0.62)。相比之下,不使用升压药的亚组死亡率有下降趋势(从2005年的47%下降到2011年的43%; P 趋势 = 0.002);同样,调整后的死亡率也显着降低(OR,0.97; 95%CI,0.95-0.99; P = 0.002)结论从2005年至2011年,我们发现感染性休克患者的院内死亡率有所下降。但是,在使用升压药的亚组中,我们发现死亡率没有显着变化。我们的数据挑战了传统观念,即过去十年中该人群的死亡率有所提高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号